Norovirus infection has characteristic clinical and epidemiological features that can allow its differentiation from other causes of gastroenteritis. Norovirus is often acquired from a contact ...

This review summarizes recent developments in norovirus research that are relevant to the prevention and management of norovirus gastroenteritis in immunocompromised patients. Noroviruses are ...

Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and sometimes dangerous source of food poisoning. Moderna’s ...

Norovirus levels are hitting highs not seen in six years, according to CDC data. Four viruses are currently circulating in the United States, which some have referred to as a "quad-demic." Data ...